I am a Lecturer with multidisciplinary teaching experience in Bioscience. I am a Fellow of the Higher Education Academy, a member of the Institute of Biomedical Science and the Biochemical Society, and maintain my registration with the HCPC as a Biomedical Scientist via appropriate continuing professional development activities.
Biological and Biomedical Sciences (Undergraduate and Postgraduate)
Research expertise and interests: Application of Computational biochemistry, molecular modelling and bioinformatics methods to investigate viral proteins and proteins of biomedical importance,
Rivera, J.F.,Baral, A.J., Nadat, F., Boyd,G., Smyth, R., Patel, H., Burman, E.L., Alameer, G., Boxall, S.A., Jackson, B.R., Baxter, E. J.,Laslo,P., Green,A.R., Kent, D.G.,Mullally, A.,& Chen, E. (2021). Zinc-dependent multimerization of mutant calreticulin is required for MPL binding and MPN pathogenesis. Blood Advances, 5(7): 1922–1932. doi: https://doi.org/10.1182/bloodadvances.2020002402
Patel, H., & Kukol, A. (2020). Integrating molecular modelling methods to advance influenza A virus drug discovery. Drug Discovery Today, 26(2), 503-510. https://doi.org/10.1016/j.drudis.2020.11.014.
Patel, H.,& Kukol, A. (2019).Prediction of ligands to universally conserved binding sites of the influenza A virus nuclear export protein. Virology, 537, 97-103.
Patel, H., & Kukol, A. (2017). Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors. Virology, 509, 112-120.
Patel, H., & Kukol, A. (2016). Recent discoveries of influenza A drug target sites to combat virus replication. Biochemical Society Transactions, 44(3), 932–936.
Patel, H., & Kukol, A. (2016). Evaluation of a novel virtual screening strategy using receptor decoy binding sites. Journal of Negative Results in BioMedicine, 15(15).
Kukol, A., & Patel, H. (2014). Influenza A nucleoprotein binding sites for antivirals: current research and future potential. Future Virology, 9(7), 625-627.